Clinical Trial Update: Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics and safety study of maraviroc in HIV-infected individuals with varying degrees of renal impairment and normal renal function to assess …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: Human Immunodeficiency Virus (HIV) Infection | Phase 4 | Status: COMPLETED | Results posted: 2009-12-21